Related references
Note: Only part of the references are listed.
Article
Immunology
Valliappan Muthu et al.
Summary: We conducted a case-control study in 25 hospitals in India to investigate the causes of a COVID-19-associated mucormycosis outbreak. The study found that cumulative glucocorticoid dose, zinc supplementation, elevated C-reactive protein, host factors (renal transplantation, diabetes mellitus, diabetic ketoacidosis during COVID-19), and rural residence were significantly associated with CAM. The study emphasizes the importance of judicious use of COVID-19 therapies and optimal glycemic control to prevent CAM.
EMERGING INFECTIOUS DISEASES
(2023)
Review
Biotechnology & Applied Microbiology
Ayushi Sharma et al.
Summary: Mucormycosis is a deadly opportunistic disease caused by a group of fungi, which easily invade the immune-compromised body and have a high fatality rate. During the COVID-19 pandemic, patients on immunosuppressive drugs and those with diabetes mellitus are at higher risk. The infection can enter the body through the respiratory tract, damaged skin, or gastrointestinal route. Early diagnosis and aggressive surgical intervention are crucial in reducing mortality rates.
FOLIA MICROBIOLOGICA
(2022)
Review
Endocrinology & Metabolism
Awadhesh Kumar Singh et al.
Summary: This systematic review analyzed the characteristics of patients with both COVID-19 and mucormycosis, finding a high proportion of cases in males, 80% with pre-existing diabetes, and a significant use of corticosteroids in treating COVID-19, contributing to mortality in some cases.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS
(2021)
Article
Otorhinolaryngology
S. Sharma et al.
Summary: A study found an association between coronavirus disease and fungal infection of the paranasal sinuses, with ethmoids being the most commonly affected sinuses. Intra-orbital extension occurred in 43.47% of cases, while intracranial extension was seen in only 8.69% of cases. Twenty-one out of 23 patients had diabetes mellitus, with 12 cases being uncontrolled, and all patients had a history of steroid use during their coronavirus treatment.
JOURNAL OF LARYNGOLOGY AND OTOLOGY
(2021)
Article
Dermatology
Shivaprakash M. Rudramurthy et al.
Summary: Globally, the incidence of COVID-19-associated mucormycosis (CAM) is rising, with a significant surge in India. The need to address misconceptions in managing and treating this infection is crucial, with a focus on early suspicion, diagnosis confirmation, glycemic control, surgical debridement, and antifungal therapy. Limited availability of amphotericin B formulations during the epidemic has led to discussions on alternative antifungal therapies.
Article
Immunology
Atul Patel et al.
Summary: This study found an increase in mucormycosis cases in India during the COVID-19 pandemic, mainly due to inappropriate glucocorticoid use, resulting in a higher mortality rate among mucormycosis patients.
EMERGING INFECTIOUS DISEASES
(2021)
Article
Ophthalmology
Mrittika Sen et al.
Summary: This study retrospectively reviewed the characteristics, treatment, and outcomes of COVID-19-associated ROCM patients during India's second wave of COVID-19 pandemic. The study found that corticosteroids and diabetes mellitus are important predisposing factors for ROCM development, and a high index of clinical suspicion and early treatment are essential for successful outcomes.
INDIAN JOURNAL OF OPHTHALMOLOGY
(2021)
Review
Infectious Diseases
Oliver A. Cornely et al.
LANCET INFECTIOUS DISEASES
(2019)
